Biolase, Inc. (BIOL) - Net Sales Margin

Innovative American plants of BIOLASE, Inc. (BIOL) create advanced systems for painless dentistry. The net profit margin trend on the GURU.Markets chart clearly demonstrates these processes, where the latest value is recorded as -78.30. High demand for patented water-jet tissue cutting provides pricing power, although the current status of asset liquidation following bankruptcy determines the company's fundamental backdrop.
Financial and market metric breakdowns for BIOLASE, Inc. (BIOL)

The Waterlase ecosystem creates high barriers to entry for competitors through physician certification and proprietary equipment. By analyzing the commercial profit margin of BIOLASE, Inc. (BIOL) on GURU.Markets, an investor assesses the monetization efficiency of this advantage. This metric is calculated as the ratio of net income to total revenue, measuring the profit share of every dollar earned. Growth in this metric confirms cost optimization and operational resilience. A stable trend guarantees business reliability during shifts in the market cycle.